Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0360674466
Thu, 24.10.2024
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Following solid sales growth of 2.6% in the first half of 2024, Galenica grew more strongly again in the third quarter and generated net sales of CHF 2,864.8 million to the end of September 2024. With growth of 4.1%, Galenica outperformed the growth of the overall pharmaceutical market (+2.9%, [ … ]
Tue, 06.08.2024
Galenica AG
Galenica AG
/ Key word(s): Strategic Company Decision
Expansion of the Executive Committee and handover of the position of CFO 06.08.2024 / 07:00 CET/CEST
Press release
Galenica is aligning its pharmacy business to an even greater focus on customers. With Stephan Mignot, Marketing for the pharmacies will have a direct seat on [ … ]
Tue, 06.08.2024
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica Group sales grew by 2.6% to CHF 1,900.0 million in the first half of 2024. Both the “Products & Care” segment and the “Logistics & IT” segment contributed to the sales growth, with growth of 3.1% and 3.0% respectively. As a result, Galenica Group sales developed more dynamical [ … ]
Mon, 22.07.2024
Galenica AG
Galenica AG
/ Key word(s): Investment
Galenica increases shareholding in Redcare Pharmacy to 10% 22.07.2024 / 18:11 CET/CEST
Press release
Today, Galenica notified the Dutch Authority for the Financial Markets (AFM) of its 10% stake in Redcare Pharmacy N.V.
As part of the strategic partnership between Galenica and Redcare Phar [ … ]
Thu, 23.05.2024
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
The Galenica Group made a good start to the new year with sales growth of 4.8% to CHF 1,255.5 million in the first four months of 2024. All Service Units performed well and contributed to the good sales performance.
The sales growth is based on a positive development of the pharmaceutical ma [ … ]
Tue, 16.04.2024
Galenica AG
Galenica AG
/ Key word(s): Bond
Galenica successfully places a bond of over CHF 100 million 16.04.2024 / 18:05 CET/CEST
Press release
Today, Galenica successfully placed a fixed rate bond of over CHF 100 million.
The bond has a term of 7 years and an annual coupon of 1.65%. The proceeds from the transaction will be used for g [ … ]
Wed, 10.04.2024
Galenica AG
Galenica AG
/ Key word(s): AGMEGM
7th Annual General Meeting: Shareholders approve all proposals 10.04.2024 / 17:29 CET/CEST
Press release
The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern. The shareholders approved all the proposals put forward by the Board of Directors. They [ … ]
Tue, 12.03.2024
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
The Galenica Group achieved strong growth with an increase in sales of 4.4% in the 2023 financial year and generated consolidated net sales of CHF 3,746.0 million. Adjusted for the extraordinary sales related to COVID-19 (self-tests, COVID-19 vaccinations and rapid tests) in the prior-year per [ … ]
Thu, 18.01.2024
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica Group sales performed well in 2023, growing by 4.4% to CHF 3,746.0 million. As expected, sales growth of 3.3% in the second half of 2023 was lower than the +5.5% recorded in the first half due to the exceptionally strong comparative period in the second half of 2022, when there was a [ … ]